SHTDY
Price
$11.69
Change
+$0.02 (+0.17%)
Updated
Apr 2 closing price
Capitalization
9.79B
ZYXI
Price
$2.25
Change
-$0.19 (-7.79%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
397.95M
20 days until earnings call
Ad is loading...

SHTDY vs ZYXI

Header iconSHTDY vs ZYXI Comparison
Open Charts SHTDY vs ZYXIBanner chart's image
Sinopharm Group
Price$11.69
Change+$0.02 (+0.17%)
Volume$7.81K
Capitalization9.79B
Zynex
Price$2.25
Change-$0.19 (-7.79%)
Volume$769
Capitalization397.95M
SHTDY vs ZYXI Comparison Chart
Loading...
SHTDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZYXI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SHTDY vs. ZYXI commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SHTDY is a Hold and ZYXI is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (SHTDY: $11.80 vs. ZYXI: $2.25)
Brand notoriety: SHTDY and ZYXI are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: SHTDY: 73% vs. ZYXI: 72%
Market capitalization -- SHTDY: $9.79B vs. ZYXI: $397.95M
SHTDY [@Medical Distributors] is valued at $9.79B. ZYXI’s [@Medical Distributors] market capitalization is $397.95M. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $9.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SHTDY’s FA Score shows that 2 FA rating(s) are green whileZYXI’s FA Score has 0 green FA rating(s).

  • SHTDY’s FA Score: 2 green, 3 red.
  • ZYXI’s FA Score: 0 green, 5 red.
According to our system of comparison, SHTDY is a better buy in the long-term than ZYXI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SHTDY’s TA Score shows that 3 TA indicator(s) are bullish while ZYXI’s TA Score has 5 bullish TA indicator(s).

  • SHTDY’s TA Score: 3 bullish, 6 bearish.
  • ZYXI’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ZYXI is a better buy in the short-term than SHTDY.

Price Growth

SHTDY (@Medical Distributors) experienced а +0.25% price change this week, while ZYXI (@Medical Distributors) price change was -7.41% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was -3.83%. For the same industry, the average monthly price growth was -6.11%, and the average quarterly price growth was -9.26%.

Reported Earning Dates

ZYXI is expected to report earnings on Apr 24, 2025.

Industries' Descriptions

@Medical Distributors (-3.83% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SHTDY($9.79B) has a higher market cap than ZYXI($398M). ZYXI has higher P/E ratio than SHTDY: ZYXI (46.30) vs SHTDY (8.26). SHTDY YTD gains are higher at: -13.043 vs. ZYXI (-71.910). SHTDY has higher annual earnings (EBITDA): 26.2B vs. ZYXI (17.9M). SHTDY has higher revenues than ZYXI: SHTDY (552B) vs ZYXI (184M).
SHTDYZYXISHTDY / ZYXI
Capitalization9.79B398M2,459%
EBITDA26.2B17.9M146,369%
Gain YTD-13.043-71.91018%
P/E Ratio8.2646.3018%
Revenue552B184M300,000%
Total CashN/A44.6M-
Total DebtN/A76.2M-
FUNDAMENTALS RATINGS
SHTDY vs ZYXI: Fundamental Ratings
SHTDY
ZYXI
OUTLOOK RATING
1..100
5051
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
94
Overvalued
PROFIT vs RISK RATING
1..100
78100
SMR RATING
1..100
10078
PRICE GROWTH RATING
1..100
7598
P/E GROWTH RATING
1..100
3090
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SHTDY's Valuation (19) in the null industry is significantly better than the same rating for ZYXI (94) in the Medical Specialties industry. This means that SHTDY’s stock grew significantly faster than ZYXI’s over the last 12 months.

SHTDY's Profit vs Risk Rating (78) in the null industry is in the same range as ZYXI (100) in the Medical Specialties industry. This means that SHTDY’s stock grew similarly to ZYXI’s over the last 12 months.

ZYXI's SMR Rating (78) in the Medical Specialties industry is in the same range as SHTDY (100) in the null industry. This means that ZYXI’s stock grew similarly to SHTDY’s over the last 12 months.

SHTDY's Price Growth Rating (75) in the null industry is in the same range as ZYXI (98) in the Medical Specialties industry. This means that SHTDY’s stock grew similarly to ZYXI’s over the last 12 months.

SHTDY's P/E Growth Rating (30) in the null industry is somewhat better than the same rating for ZYXI (90) in the Medical Specialties industry. This means that SHTDY’s stock grew somewhat faster than ZYXI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SHTDYZYXI
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 28 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
68%
Bearish Trend 4 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
SHTDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZYXI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INCZY1.550.03
+1.97%
Incitec Pivot Ltd.
LRLCY77.21-0.16
-0.21%
L'Oreal Co.
GXYYY19.38-0.12
-0.62%
Galaxy Entertainment Group, Ltd.
CHKR0.44-0.01
-1.21%
Chesapeake Granite Wash Trust
LNVGY25.31-2.07
-7.56%
Lenovo Group Ltd.

SHTDY and

Correlation & Price change

A.I.dvisor tells us that SHTDY and YI have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHTDY and YI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHTDY
1D Price
Change %
SHTDY100%
+0.93%
YI - SHTDY
21%
Poorly correlated
-5.19%
SHTDF - SHTDY
19%
Poorly correlated
N/A
HSIC - SHTDY
11%
Poorly correlated
-3.83%
ZYXI - SHTDY
9%
Poorly correlated
-7.79%
PDCO - SHTDY
8%
Poorly correlated
-0.26%
More

ZYXI and

Correlation & Price change

A.I.dvisor tells us that ZYXI and OMI have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZYXI and OMI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZYXI
1D Price
Change %
ZYXI100%
-7.79%
OMI - ZYXI
28%
Poorly correlated
-6.22%
HSIC - ZYXI
17%
Poorly correlated
-3.83%
PDCO - ZYXI
14%
Poorly correlated
-0.26%
GEG - ZYXI
11%
Poorly correlated
+0.26%
AMFPF - ZYXI
10%
Poorly correlated
N/A
More